MARKET

ELDN

ELDN

Eledon Pharmaceuticals Inc
NASDAQ
4.530
+0.040
+0.89%
After Hours: 4.570 +0.04 +0.88% 16:30 02/14 EST
OPEN
4.530
PREV CLOSE
4.490
HIGH
4.575
LOW
4.400
VOLUME
112.25K
TURNOVER
--
52 WEEK HIGH
5.54
52 WEEK LOW
1.520
MARKET CAP
270.62M
P/E (TTM)
-3.8080
1D
5D
1M
3M
1Y
5Y
1D
Eledon Pharmaceuticals (ELDN) Receives a Buy from Noble Financial
TipRanks · 5d ago
Weekly Report: what happened at ELDN last week (0203-0207)?
Weekly Report · 5d ago
Eledon announces tegoprubart use in transplant of pig kidney into human
TipRanks · 02/07 15:10
Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human
Barchart · 02/07 09:00
Weekly Report: what happened at ELDN last week (0127-0131)?
Weekly Report · 02/03 11:38
Eledon Pharmaceuticals: At The Forefront Of The Organ Transplant Management Business
Seeking Alpha · 01/28 16:27
Eledon initiated with a Buy at Guggenheim on tegoprubart opportunity
TipRanks · 01/28 13:30
Eledon Pharmaceuticals initiated with a Buy at Guggenheim
TipRanks · 01/28 11:25
More
About ELDN
Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing immune-modulating therapies for the management and treatment of life-threatening conditions. The Company’s lead investigational product is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand, a well-validated biological target within the costimulatory CD40/CD40L cellular pathway. The central role of CD40L signaling in both adaptive and innate immune cell activation and function positions it as an attractive target for non-lymphocyte depleting, immunomodulatory therapeutic intervention. Tegoprubart is engineered to potentially both improve safety and provides pharmacokinetic, pharmacodynamic, and dosing advantages. CD40L is primarily expressed on activated CD4+ T cells, platelets, and endothelial cells while the CD40 receptor is constitutively expressed on antigen-presenting cells, such as macrophages and dendritic cells, as well as B cells.

Webull offers Eledon Pharmaceuticals Inc stock information, including NASDAQ: ELDN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELDN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ELDN stock methods without spending real money on the virtual paper trading platform.